Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-22T20:14:42.228Z Has data issue: false hasContentIssue false
  • English
  • Français

Nutrition Discussion Forum

Published online by Cambridge University Press:  09 March 2007

Gediminas A. BiziuleviČius
Gediminas A. BiziuleviČius*
Affiliation:
Immunomodulators Research Sector, Institute of Immunology, Vilnius University, 29 Mole?tu? plentas, LT-08409 Vilnius, Lithuania
*
[email protected]
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Review Article
Information
British Journal of Nutrition , Volume 92 , Issue 6 , December 2004 , pp. 1009 - 1012
Copyright
Copyright © The Nutrition Society 2004

References

Alexander, C & Rietschel, ET (2001) Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 7, 167–202.Google ScholarPubMed
Arai, S, Morinaga, Y, Yoshikawa, T, Ichiishi, E, Kiso, Y, Yamazaki, M, Morotomi, M, Shimizu, M, Kuwata, T & Kaminogawa, S (2002) Recent trends in functional food science and the industry in Japan. Biosci Biotechnol Biochem 66, 2017–2029.CrossRefGoogle Scholar
Ashwell, M (2002) Concepts of Functional Foods: ILSI Europe Concise Monograph Series Brussels ILSI EuropeGoogle Scholar
Beutler, B (2004) Innate immunity: an overview. Mol Immunol 40, 845–859.CrossRefGoogle Scholar
Biziulevičius, GA, Kislukhina, OV, Zukaite, V, Normantiene, T, Arestov, IG (2002) Stimulation of microbial autolytic system by tryptic casein hydrolysate. Int J Antimicrob Agents 20, 361–365.CrossRefGoogle ScholarPubMed
Biziulevičius, GA, Kislukhina, OV, Zukaite, V, Normantiene, T, Biziuleviciene, G, Arestov, IG (2003) Non-specific immunity-enhancing effects of tryptic casein hydrolysate versus Fermosorb for treatment/prophylaxis of newborn calf colibacillosis. FEMS Immunol Med Microbiol 39, 155–161.CrossRefGoogle Scholar
Bocci, V (1992) The neglected organ: bacterial flora has a crucial immunostimulatory role. Perspect Biol Med 35, 251–260.CrossRefGoogle Scholar
Brown, GD & Gordon, S (2003) Fungal β-glucans and mammalian immunity. Immunity 19, 311–315.CrossRefGoogle ScholarPubMed
Chandra, RK (1996) Nutrition, immunity and infection: from basic knowledge of dietary manipulation of immune responses to practical application of ameliorating suffering and improving survival. Proc Natl Acad Sci USA 93, 14304–14307.CrossRefGoogle ScholarPubMed
Clare, DA, Catignani, GL & Swaisgood, HE (2003) Biodefense properties of milk: the role of antimicrobial proteins and peptides. Curr Pharmaceut Design 9, 1239–1255.CrossRefGoogle ScholarPubMed
Floris, R, Recio, I, Berkhout, B & Visser, S (2003) Antibacterial and antiviral effects of milk proteins and derivatives thereof. Curr Pharmaceut Design 9, 1257–1275.CrossRefGoogle Scholar
Ginsburg, I (2001) Cationic peptides from leukocytes might kill bacteria by activating their autolytic enzymes causing bacteriolysis: why are publications proposing this concept never acknowledged? (letter). Blood 97, 2530–2531.CrossRefGoogle Scholar
Ginsburg, I (2004) Bactericidal cationic peptides can also function as bacteriolysis-inducing agents mimicking beta-lactam antibiotics; it is enigmatic why this concept is consistently disregarded. Med Hypotheses 62, 367–374.CrossRefGoogle ScholarPubMed
Goldman, RC & Branstrom, A (1999) Targeting cell wall synthesis and assembly in microbes: similarities and contrasts between bacteria and fungi. Curr Pharmaceut Design 5, 473–501.CrossRefGoogle ScholarPubMed
Ibrahim, HR, Matsuzaki, T & Aoki, T (2001) Genetic evidence that antibacterial activity of lysozyme is independent of its catalytic function. FEBS Lett 506, 27–32.CrossRefGoogle Scholar
Kislukhina, OV, Kuznetsova, TA, Kalunyants, KA, Bandoyan, AK (inventors: All-Union Biotechnical Research Institute, assignee) (1981) Method for preparation of an activator of microbial autolysis. USSR Invention 969, 715Google Scholar
Kitts, DD & Weiler, K (2003) Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery. Curr Pharmaceut Design 9, 1309–1323.CrossRefGoogle ScholarPubMed
Koch, AL (2000) The exoskeleton of bacterial cells (the sacculus): still a highly attractive target for antibacterial agents that will last for a long time. Crit Rev Microbiol 26, 1–35.CrossRefGoogle Scholar
Korhonen, H & Pihlanto, A (2003) Food-derived bioactive peptides – opportunities for designing future foods. Curr Pharmaceut Design 9, 1297–1308.CrossRefGoogle ScholarPubMed
Matin, MA & Otani, H (2001) Antimicrobial and cytotoxic peptides released from milk proteins by the action of mammalian gastrointestinal proteinases. Curr Res Adv Agric Biol Chem 1, 23–36.Google Scholar
Meisel, H & FitzGerald, RJ (2003) Bifunctional peptides from milk proteins: mineral binding and cytomodulatory effects. Curr Pharmaceut Design 9, 1289–1295.Google Scholar
Milner, JA (2002) Functional foods and health: a US perspective. Br J Nutr 88 Supp. 2151–158.CrossRefGoogle Scholar
Pellegrini, A (2003) Antimicrobial peptides from food proteins. Curr Pharmaceut Design 9, 1225–1238.CrossRefGoogle ScholarPubMed
Powers, J-PS & Hancock, REW (2003) The relationship between peptide structure and antibacterial activity. Peptides 24, 1681–1691.CrossRefGoogle ScholarPubMed
Sava, G (1996) Pharmacological aspects and therapeutic applications of lysozymes.In Lysozymes: Model Enzymes in Biochemistry and Biology, 433–449 [Jollès, P, editors]. Basel: Birkhäuser Verlag.CrossRefGoogle Scholar
Scott, MG & Hancock, REW (2000) Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit Rev Immunol 20, 407–431.CrossRefGoogle ScholarPubMed
Shockman, GD, Höltje, J-V (1994) Microbial peptidoglycan (murein) hydrolases Bacterial Cell Wall, 131–166 [Ghuysen, J-MHakenbeck, R, editors]. Amsterdam: Elsevier.CrossRefGoogle Scholar
Smith, TJ, Blackman, SA & Foster, SJ (2000) Autolysins of Bacillus subtilis: multiple enzymes with multiple functions. Microbiology 146, 249–262.CrossRefGoogle ScholarPubMed
Werner, GH, Jollès, P (1996) Immunostimulating agents: what next? A review of their present and potential medical applications. Eur J Biochem 242, 1–19.CrossRefGoogle ScholarPubMed
White, S, McIntyre, M, Berry, DR & McNeil, B (2002) The autolysis of industrial filamentous fungi. Crit Rev Biotechnol 22, 1–14.CrossRefGoogle ScholarPubMed
Yamamoto, N, Ejiri, M & Mizuno, S (2003) Biogenic peptides and their potential use. Curr Pharmaceut Design 9, 1345–1355.CrossRefGoogle ScholarPubMed
Yoshikawa, M, Takahashi, M & Yang, S (2003) Delta opioid peptides derived from plant proteins. Curr Pharmaceut Design 9, 1325–1330.CrossRefGoogle ScholarPubMed
Zhang, L & Falla, TJ (2004) Cationic antimicrobial peptides – an update. Expert Opin Investig Drugs 13, 97–106.CrossRefGoogle ScholarPubMed